Janney Montgomery Scott’s First Trust Nasdaq Pharmaceuticals ETF FTXH Stock Holding History

Janney Montgomery Scott’s Portfolio FTXH Stock Details FTXH Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2024 Q4	–	Sell	-12,435	Closed	-$359K	–	2751
2024 Q3	$359K	Sell	12,435 -5,348	-30%	-$153K	﹤0.01%	2182
2024 Q2	$484K	Sell	17,783 -18,981	-52%	-$508K	﹤0.01%	1916
2024 Q1	$1.03M	Buy	+36,764	New	+$1.01M	﹤0.01%	1509
2023 Q2	–	Sell	-10,574	Closed	-$276K	–	2663
2023 Q1	$276K	Sell	10,574 -107	-1%	-$2.87K	﹤0.01%	2100
2022 Q4	$293K	Buy	10,681 +305	+3%	+$8.12K	﹤0.01%	2146
2022 Q3	$249K	Buy	+10,376	New	+$268K	﹤0.01%	2140

Other funds holding FTXH

LPL Financial San Diego, California $377B AUM 19.32% 1-Year Est. Return

Susquehanna International Group Bala Cynwyd, Pennsylvania $893B AUM 36.07% 1-Year Est. Return

Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return

Envestnet Asset Management Chicago, Illinois $374B AUM 17.66% 1-Year Est. Return

AIP

Ameritas Investment Partners Lincoln, Nebraska $3.25B AUM 28.52% 1-Year Est. Return

Cambridge Investment Research Advisors Fairfield, Iowa $38.8B AUM 21.88% 1-Year Est. Return

WFA

WMG Financial Advisors Knoxville, Tennessee $265M AUM 26.03% 1-Year Est. Return

VCM

Vivaldi Capital Management Chicago, Illinois $723M AUM 30.89% 1-Year Est. Return

SPIA

Steward Partners Investment Advisory New York $19.6B AUM 22.89% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Janney Montgomery Scott's FTXH Position: Q4 2024 in Review

Janney Montgomery Scott sold out of First Trust Nasdaq Pharmaceuticals ETF (FTXH) in Q4 2024, closing a stake of 12,435 shares — an estimated $359K sold.

Janney Montgomery Scott first reported a position in FTXH in Q3 2022 and held it in 6 quarters. The position peaked at $1.03M in Q1 2024. 21 funds tracked by Wall St. Rank hold FTXH as of Q4 2024.

Janney Montgomery Scott reported no remaining First Trust Nasdaq Pharmaceuticals ETF position as of Q4 2024 after selling out during the quarter.
Janney Montgomery Scott sold 12,435 First Trust Nasdaq Pharmaceuticals ETF shares in Q4 2024, an estimated $359K.
Janney Montgomery Scott first reported a position in First Trust Nasdaq Pharmaceuticals ETF in Q3 2022 and held it in 6 quarters.
Janney Montgomery Scott's First Trust Nasdaq Pharmaceuticals ETF position peaked at $1.03M in Q1 2024.
21 funds tracked by Wall St. Rank held First Trust Nasdaq Pharmaceuticals ETF as of Q4 2024.

Based on Janney Montgomery Scott's 13F filing for Q4 2024, filed 17 Jan 2025.